Changchun High-Tech Industries News

Changchun Hi-Tech (000661): Short-term profit pressure to accelerate product development

Western SecuritiesNov 2 07:23

Changchun Hi-Tech (000661): Jinsai Pharmaceutical's revenue transformation continues to advance steadily

Galaxy SecuritiesOct 25 00:00

Changchun Hi-Tech (000661): Short-term performance is under pressure, and strategic transformation is progressing steadily

gf secAug 20 07:36

Changchun Hi-Tech (000661): Short-term performance under pressure, diversified product layout helps long-term development

Debon SecuritiesAug 18 14:26

Changchun Hi-Tech (000661): Steady growth in 24H1 revenue growth, increased investment in innovation and transformation

everbrightAug 18 00:00

Changchun Hi-Tech (000661): Under a high base, the investment in the Jinsai stable transformation cycle increased

Aug 16 00:00

Changchun Hi-Tech (000661): Cost-side short-term pressure product layout continues to deepen

Aug 15 00:00

Changchun Hi-Tech (000661): Optimistic about the transformation from large single products to multiple drivers - Changchun Hi-Tech In-depth Report

Jul 14 00:00

Changchun Hi-Tech (000661): Growth hormone maintains resilience and continues to advance in the research pipeline

May 14 00:00

Southwest Securities released a research report on April 22 stating that it gave Changchun Hi-Tech (000661.SZ) a purchase rating. The main reasons for the rating include: 1) steady growth in growth hormone; 2) continued dosage of the shingles vaccine; 3)

Zhitong FinanceApr 23 16:25

Changchun Hi-Tech (000661): Increased proportion of long-term growth hormone continues to be realized in the research pipeline

Apr 22 00:00

Changchun Hi-Tech (000661): Revenue is growing steadily, and new products are ready to go

Apr 22 00:00

Tianfeng Securities released a research report on April 11 stating that it gave Changchun Hi-Tech (000661.SZ) a purchase rating. The main reasons for the rating include: 1) the growth hormone sector is progressing steadily, and new businesses are growing

Zhitong FinanceApr 11 19:05

Changchun Hi-Tech (000661): Growth hormone sector is steadily advancing research and development and continuous improvement

Apr 11 18:42

Changchun Hi-Tech (000661) 2023 Annual Report Review: The performance is in line with expectations and actively promotes the launch of new products

Apr 2 00:00

Changchun Hi-Tech (000661): Increased proportion of long-lasting water needles, steady progress in innovation and transformation

Mar 27 00:00

Changchun Hi-Tech (000661): Growth hormone is growing steadily and is ready to go in the research pipeline

Mar 22 00:00

Changchun Hi-Tech (000661) Annual Report Review Report: Long-acting Growth Hormone Releases Drive Performance Growth, Vaccine Subsidiary Creates Second Growth Pole

Mar 20 12:41

Changchun Hi-Tech (000661): Steady growth throughout the year, new products create the second growth engine

Mar 20 09:31

Changchun Hi-Tech (000661): Growth hormone maintains resilience and rewards shareholders with a high percentage of dividends

Mar 20 00:00